Breaking News
Otolith Labs Closes $3.3 Million in Seed Funding and Receives FDA Breakthrough Device Designation
Investors include Mark Cuban and other experienced MedTech investors including 4 leading ENTs. Otolith Labs’ noninvasive Vestibular System Masking (nVSM) technology is designed to provide acute treatment for vestibulogenic vertigo. Otolith’s headworn medical device applies localized mechanical stimulation to the vestibular system through calibrated vibrations. It is primarily intended for use by chronic vertigo patients, for whom there are limited treatment options.
In The News
Otolith Receives ISO 13485 Certification for Medical Devices Quality Management Systems from BSI
This is an important milestone for medical device companies.
Otolith Presents at Auditory & Vestibular Translational Research Day
Otolith’s Chief Science Officier, Didier Depireux, Ph. D, presented on Otolith’s novel vertigo device.
Increased Bone Conducted Vibration Reduces Motion Sickness
Results from a study testing bone conductive vibrations proved the device decreases nausea from motion sickness.
Inventor May Have Cured Motion Sickness Without Drugs, Could Mean a Lot to the US Military
Discuses how Otolith technology could effect military training.
Otolith Receives Breakthrough Device Designation from FDA
Otolith Labs announces closing of $3.3 Million in seed funding, as well as receiving “Breakthrough Device” Designation from FDA.
Selected as Top Five Finalist for the MedTech Innovator Execution Award Competition
The selection was made during the pre-conference virtual live stream on September 22, 2021.
D.C. Biotech is Raising Millions to Advance Medical Device for Vertigo
CEO Sam Owen discusses Otolith Labs usage of investor funding and the companies journey the past few years.
This New Device Could Solve VR Motion Sickness
OtoTech combats motion-induced nausea, including side effects of VR usage, without the side effects of drugs.
Otolith Labs is Proud to Sponsor VeDa
The Vestibular Disorder Association provides educational and support resources to people suffering from chronic vertigo and vestibular disorders.
MedTech Innovator Selects Otolith in Top 50 Medtech Startups
MedTech innovator unveils top 50 medtech startups selected for Annual showcase and accelerator, which includes Otolith Labs.
Selected in 101 Best Washington Based Medical Device Startups
Otolith Labs selected as one of 101 top Washington based Medical Device companies by The Startup Pill.
Electronic Headband for Drug-Free Motion Sickness Therapy
Medgadget describes Otolith Labs technology and the positive impact it has on motion sickness symptoms.
NASA iTech 2020 Cycle 1 Winner
Through NASA’s iTech initiative, the agency discovers and assesses technologies that could help it accomplish future missions. Otolith Labs was one of the three winning teams in 2020.
Otolith Labs Interviewed on This Week In Hearing Episode
Dr. Robert Traynor, Ed.D., interviews Otolith Labs CEO and CSO on This Week In Hearing, presented by Hearing Health & Technology Matters.
Development of Therapeutic Headband for Vertigo Sufferers
Washington Business Journal talks about Otolith Labs plan for FDA approval and the funding neccesary.
Recognition
Medtech Innovator Accelerator
Halcyon Incubator
